The functional relevance of passenger leukocytes and microchimerism for heart allograft acceptance in the rat

Nature Medicine

Volumn 5, Issue 11, 1999, Pages 1292-1297

  Ko, Saiho ^a   Deiwick, Andrea ^a   Jäger, Mark D ^a   Dinkel, Astrid ^a   Rohde, Frank ^a   Fischer, Rainer ^a   Tsui, Tung Yu ^a   Rittmann, Karl L ^a   Wonigeit, Kurt ^a   Schlitt, Hans J ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD45 ANTIGEN; CYCLOSPORIN; CYTOKINE; MONOCLONAL ANTIBODY;

ALLOTYPE; ALTERNATIVE RNA SPLICING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN DETECTION; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; GRAFT FAILURE; GRAFT SURVIVAL; HEART TRANSPLANTATION; HISTOCOMPATIBILITY; HISTOINCOMPATIBILITY; IMMUNOHISTOLOGY; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; LEUKOCYTE; LYMPHOCYTE DEPLETION; MICROCHIMERISM; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIBODIES, MONOCLONAL; BASE SEQUENCE; CYTOKINES; DNA PRIMERS; GRAFT SURVIVAL; HEART TRANSPLANTATION; LEUKOCYTES; RATS; RATS, INBRED LEW; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSPLANTATION CHIMERA; TRANSPLANTATION, HOMOLOGOUS;

EID: 20244364353     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/15248     Document Type: Article

References (40)

1. Starzl, T.E. et al. Cell migration, chimerism, and graft acceptance. Lancet 339, 1579-1582 (1992).
2. Starzl T.E. et al. Cell migration and chimerism after whole organ transplantation: The basis of graft acceptance. Hepatology 17, 1127-1152 (1993).
3. Starzl, T.E. et al. Donor cell chimerism permitted by immunosuppressive drugs: a new view of organ transplantation. Immunol. Today 14, 326-332 (1993).
4. Starzl, T.E. & Zinkernagel, R.M. Antigen localization and migration in immunity and tolerance. N. Engl. J. Med. 339, 1905-1913 (1998).
5. McSherry, C. et al. Sequential measurement of peripheral blood allogeneic microchimerism levels and association with pulmonary function. Transplantation 62, 1811-1818 (1996).
6. Wood, K. & Sachs, D.H. Chimerism and transplantation tolerance: cause and effect. Immunol. Today 17, 584-587 (1996).
7. Schlitt, H.J. et al. Patterns of donor-type microchimerism after heart transplantation. Lancet 343, 1469-1471 (1994).
8. Schlitt, H.J., Hundrieser, J., Ringe, B. & Pichlmayr, R. Systemic microchimerism of donor-type associated with irreversible acute liver graft rejection eight years after transplantation. N. Engl. J. Med. 330, 646-647 (1994).
9. Hisanaga, M. et al. Development, stability, and clinical correlations of allogeneic microchimerism after solid organ transplantation. Transplantation 61, 40-45 (1996).
10. Wonigeit, K. Characterization of the RT-Ly-1 and RT-Ly-2 alloantigenic systems by congenic rat strains. Transplant. Proc. 11, 1631-1635 (1979).
11. Kampinga, J. et al. RT7-defined alloantigens in rats are part of the leukocyte common antigen family. Scand. J. Immunol. 31, 699-710 (1990).
12. Heidecke, C.-D. et al. α/β-T cell receptor-directed therapy in rat allograft recipients. Transplantation 61, 948-956 (1996).
13. Lechler, R.I. & Batchelor, J.R. Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells. J. Exp. Med. 155, 31-41 (1982).
14. Sun, J. et al. Deletion of spontaneous rat liver allograft acceptance by donor irradiation. Transplantation 60, 233-236 (1995).
15. Schlitt, H.J. Is microchimerism needed for allograft tolerance? Transplant. Proc. 29, 82-84 (1997).
16. Ueda, M. et al. Development of microchimerism in pediatric patients after living-related liver transplantation. Clin. Transplant. 11, 193-199 (1997).
17. Schlitt, H.J. et al. Persistence of donor lymphocytes in liver allograft recipients. Transplantation 56, 1001-1007 (1993).
18. Larsen, C.P, Morris, P. & Ausytn, J.M. Migration of dendritic leukocytes from cardiac allografts into host spleens: a novel pathway for initiation of rejection. J. Exp. Med. 171, 307-314 (1990).
19. Murase, N. et al. Effect in supralethally irradiated rats of granulocyte colony-stimulating factor and lisofylline on hematopoietic reconstitution by syngeneic bone marrow or whole organ passenger leukocytes. Transplantation 63, 1840-1843 (1997).
20. Demetris, A.J. et al. Hematolymphoid cell trafficking, microchimerism, and GVH reactions after liver, bone marrow, and heart transplantation. Transplant. Proc. 25, 3337-3344 (1993).
21. Santin, A.D. et al. The effects of irradiation on the expression of a tumour rejection antigen (heat shock protein gp96) in a human cervical cancer. Int. J. Radiat. Biol. 73, 699-704 (1998).
22. Sriwatanawongsa, V., Davies, H.ff., & Calne, R.Y. The essential roles of parenchymal tissues and passenger leukocytes in the tolerance induced by liver grafting in rats. Nature Med. 1, 428-432 (1995).
23. Ehl, S. et al. Antigen persistence and time of T-cell tolerization determine the efficacy of tolerization protocols for prevention of skin graft rejection. Nature Med. 4, 1015-1019 (1998).
24. Schwarz, R.H. A cell culture model for T lymphocyte clonal anergy. Science 248, 1349-1356 (1990).
25. Lombardi, G. et al. Antigen presentation by T cells inhibits IL-2 production and induces IL-4 release due to altered cognate signals. J. Immunol. 156, 2769-2775 (1996).
26. Tsui, T.Y., Deiwick, A., Ko, S. & Schlitt, H.J. Specific immunosuppression by post-operative infusion of allogeneic spleen cells. Requirement of donor MHC expression and graft-versus-host reactivity. Transplantation (in the press).
27. Thomas, J.M. et al. Veto cells in transplantation tolerance. Clin. Transplant. 8, 195-203 (1994).
28. Thomas, J.M. Further studies of veto activity in rhesus monkey bone marrow in relation to allograft tolerance and chimerism. Transplantation 57, 101-115 (1994).
29. Raddatz, C., Deiwick, A., Sato, T. & Schlitt, H.J. Inhibition of cytotoxic alloreactivity by human allogeneic mononuclear cells: evidence for veto function of CD2+ cells. Immunology 94, 101-108 (1998).
30. Tomita, Y., Khan, A. & Sykes, M. Role of intrathymic clonal deletion and peripheral anergy in transplantation tolerance induced by bone marrow transplantation in mice conditioned with a nonmyeloablative regimen. J. Immunol. 153 1087-1098 (1994).
31. Khan, A., Tomita, Y. & Sykes, M. Thymic dependence of loss of tolerance in mixed allogeneic chimeras after depletion of donor antigen. Transplantation 62 380-387 (1996).
32. Ono, K. & Lindsey, E.S. Improved technique of heart transplantation in rats. J. Thorac. Cardiovasc. Surg. 57, 225-229 (1969).
33. Schwinzer, R., Hedrich H.-J. & Wonigeit, K. T cell differentiation in athymic nude rats (rnu/rnu): demonstration of a distorted T cell subset structure by flow cytometry analysis. Eur. J. Immunol. 19, 1841-1847 (1989).
34. Hoffman, R.A. et al. Alloantigen-induced activation of rat splenocytes is regulated by the oxidative metabolism of L-arginine. J. Immunol. 145, 2220-2226 (1990).
35. Wood, P.J. et al. Prevention of chronic rejection by donor-specific blood transfusion in a new model of chronic cardiac allograft rejection. Transplantation 61, 1440-1443 (1996).
36. Demetris, A.J. et al. Analysis of chronic rejection and obliterative arteriopathy. Am. J. Pathol. 150, 563-578 (1997).
37. Schmid, C., Heemann, U. & Tilney, N.L. Retransplantation reverses mononuclear infiltration but not myointimal proliferation in a rat model of chronic cardiac allograft rejection. Transplantation 61, 1695-1699 (1996).
38. Strehlau, J. et al. The intragraft gene activation of markers reflecting T-cell-activation and -cytotoxicity analysed by quantitative RT-PCR in renal transplantation. Clin. Nephrol. 46, 30-33 (1996).
39. Siebert, P.D. & Larrick, J.W. PCR MIMICS: competitive DNA fragments for use as internal standards in quantitative PCR. BioTechniques 14, 244-249 (1993).
40. Siegling, A. et al. A novel multispecific competitor fragment for quantitative PCR analysis of cytokine gene expression in rats. J. Immunol. Method 177, 23-28 (1994).